Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Radiation Oncology (London, England)|May 14, 2026
Adjuvant stereotactic pancreatic radiotherapy (SPARTA trial): interim safety analysis of an ongoing phase II single center prospective studyMaria Massaro, Tiziana Comito, Ciro Franzese, et al.
Lung Cancer (Amsterdam, Netherlands)|January 12, 2020
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intentMichela Buglione, Barbara Alicja Jereczek-Fossa, Marco Lorenzo Bonù, et al.
Cancers|September 13, 2025
Oligometastatic Mesothelioma Treated with Ablative Radiotherapy (OMAR): A Multicenter StudyDavide Franceschini, Paolo Ghirardelli, Patricia Frrokaj, et al.
Plos One|November 14, 2019
Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approachAlessio Bruni, Niccolò Giaj-Levra, Patrizia Ciammella, et al.
Clinical Lung Cancer|March 26, 2021
The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLCMarco Perna, Vieri Scotti, Patrizia Ciammella, et al.
Frontiers in Oncology|October 15, 2021
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung CancerAlessio Bruni, Vieri Scotti, Paolo Borghetti, et al.
Cancer Investigation|September 27, 2014
Docetaxel in castration-resistant prostate cancer: a single-centre experienceBeatrice Detti, Detti Beatrice, Davide Franceschini, et al.
Frontiers in Oncology|December 6, 2021
Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung CancerAlessio Bruni, Vieri Scotti, Paolo Borghetti, et al.
Human Molecular Genetics|January 18, 2014
A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's diseaseMarianne R Smith, Adeela Syed, Tamas Lukacsovich, et al.
Neuro-Oncology|May 29, 2021
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIROSilvia Scoccianti, Emanuela Olmetto, Valentina Pinzi, et al.
Pageof 16